Director, HCP Marketing

Woburn, MA (Hybrid)

$214K/yr – $277K/yrDirector/Executive10+ years expFull time

Posted 2 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and drive the RP1 HCP marketing launch, leading cross-functional collaboration with insights, analytics, and medical affairs to deliver KPIs and adapt plans post-approval.

  • Lead cross-functional launch strategy and KPI development
  • Engage KOLs, patients, caregivers, and advocacy groups for ROI-driven tactics
  • Oversee HCP AOR, agency relationships, budgets, and compliance

Job Description

Responsibilities

  • Lead RP1 HCP marketing, working with a cross functional launch team to develop and execute the marketing strategies for the initial launch of RP1 in PD-1 failed melanoma.
  • Identifies and seeks input from internal and external experts (KOLs, Patients, Caregivers, & Advocacy groups) to ensure our tactical plans achieve the highest ROI as possible and that we adapt our tactics based on their success and the needs of the customer.
  • Manages commercial advisory board meetings to ensure insights are gathered to inform success of launch and adapt as necessary in the post approval setting.
  • Develop actionable launch initiatives along with KPIs to measure their performance.
  • Collaborates and plays a leading role in the annual strategic brand plan and tactical plan.
  • Establish effective partnerships cross functionally including insights & analytics, medical affairs, R&D, market access, regulatory, operations, and others to ensure success of the launch.
  • Lead contact for HCP AOR, campaign development, and personal and non-personal strategies.
  • Manage agency relationships and budgets that effectively achieve desired goals that are balanced with the financial objectives of the broader commercial organization.
  • Ensure compliance with corporate policies and procedures, as well as US healthcare laws and regulations.
  • Perform other duties as assigned

Requirements

  • Bachelor's Degree; MBA or advanced degree preferred. Equivalent life science career experience would be accepted.
  • 10+ years' experience in marketing, sales, or other commercial roles in the life sciences industry, directly or as agency partner in strategic and operational role, preferably including 2-3+ years working in oncology solid tumors or other related specialty areas.
  • Launch experience in oncology or specialty care products is required and skin cancer experience a plus.
  • Strong written and verbal communication skills, strong presentation skills appropriate to senior stakeholders.
  • Ability to lead, collaborate and influence cross-functional teams within an organization.
  • Flexible, adaptable, diplomatic, and able to effectively deal with ambiguity and solve problems through innovative thinking.
  • Possesses a good blend of strategic and operational experience with the ability to see the big picture and strong attention to detail.
  • Ability to conduct business travel outside Massachusetts approximately 10-25% of time

Benefits

  • medical, dental, and vision insurance
  • 401k match
  • flexible time off
  • a number of paid holidays including year-end shutdown
Replimune logo

Replimune

Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.

Founded in 2015
Woburn, Massachusetts, USA
465 employees (16 in marketing)

Traffic Signals

Monthly Visitors
7.8K
Traffic Source Mix
Search
46.7%
Direct
40.7%
Referral
5.9%
Social
5.5%
Paid
1%

Headcount Trend

Current headcount: ~460

Marketing Team

Marketing Team Size
16 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.2B
Last Raise
$140M
Post IPO Equity, 1 years ago

Funding History

  • Nov 2024
    Post IPO Equity • $140M
  • Jun 2024
    Post IPO Equity • $100M
  • Dec 2022
    Post IPO Equity • $225M

Recent News